EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study

Anna Vassiliou, Temidayo Osunronbi, Synthia Enyioma, Gerardo Rago, Afroditi Karathanasi, Aruni Ghose iD, Matin Sheriff, Christos Mikropoulos iD, Elisabet Sanchez, Michele Moschetta, Cyrus Chargari, Elie Rassy iD und 1 weitere

Cancers · 06.09.2023 · 15 (18) · 4432

DOI: 10.3390/cancers15184432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 06.09.2023. Verfasst von Anna Vassiliou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Metastatic spinal cord compression (MSCC) is a severe complication of cancer that can lead to irreversible neurological impairment, necessitating prompt recognition and intervention. This retrospective, single-centre study aimed to determine the prognostic factors and survival rates among patients presenting with MSCC secondary to lung cancer. Methods and Materials: We identified 74 patients with epidural metastases-related spinal cord compression and a history of lung cancer through the electronic database of Medway Maritime Hospital in the United Kingdom (UK), spanning the period from April 2016 to September 2021. Among them, 39 were below 55 years old, while 35 were aged 55 years or older; 24 patients were diagnosed with small cell lung cancer (SCLC), and 50 patients had non-small cell lung cancer (NSCLC).

Results

The median overall survival (OS) was 5.5 months, with 52 out of 74 patients dying within 6 months of diagnosis with MSCC. For the entire cohort, the statistically significant variables on multi-variate analysis were cancer type (NSCLC had improved OS), the number of involved vertebrae (one to two vertebrae involvement had improved OS), and the time taken to develop motor deficits (≤10 days to develop motor deficits had worsened OS). For the NSCLC cohort, the statistically significant variables on multivariate analysis were molecular alterations (patients with epidermal growth factor receptor (EGFR) mutation), pre-treatment ambulatory status, Eastern Cooperative Oncology Group (ECOG) performance status, and the time taken to develop motor deficits.

Conclusions

Within the entire cohort, patients diagnosed with NSCLC and spinal metastases affecting one to two vertebrae exhibited enhanced OS. Within the NSCLC subgroup, those with EGFR mutations who were ambulatory and possessed an ECOG performance status of 1–2 demonstrated improved OS. In both the entire cohort and the NSCLC subgroup, the development of motor deficits within a period of ≤10 days was associated with poor OS.

Schlagwörter

Stichwörter der Autor:innen

lung cancermetastatic spinal cord compressionprognostic factorssurvivor

Autor:innen und Institutionen

  • Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.
  • Hull University Teaching Hospital NHS Foundation Trust, Hull HU1 3SA, UK.
  • Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK.
  • Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London HA6 2RN, UK.
  • Department of Urology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.
  • Department of Medical Oncology, St Luke's Cancer Centre, Royal Surrey Hospital, Guildford GU1 1EB, UK.

ORCID-Profile: Aruni Ghose, Christos Mikropoulos, Elie Rassy, Stergios Boussios

Zitieren

APA

Vassiliou, A., Osunronbi, T., Enyioma, S., Rago, G., Karathanasi, A., Ghose, A., Sheriff, M., Mikropoulos, C., Sanchez, E., Moschetta, M., Chargari, C., Rassy, E., & Boussios, S. (2023). Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study. Cancers, 15(18), 4432. https://doi.org/10.3390/cancers15184432

Vancouver

Vassiliou A, Osunronbi T, Enyioma S, Rago G, Karathanasi A, Ghose A, et al. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study. Cancers. 2023;15(18):4432. doi:10.3390/cancers15184432

BibTeX
@article{Vassiliou2023,
  author = {Vassiliou, Anna and Osunronbi, Temidayo and Enyioma, Synthia and Rago, Gerardo and Karathanasi, Afroditi and Ghose, Aruni and Sheriff, Matin and Mikropoulos, Christos and Sanchez, Elisabet and Moschetta, Michele and Chargari, Cyrus and Rassy, Elie and Boussios, Stergios},
  title = {Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {18},
  pages = {4432},
  doi = {10.3390/cancers15184432}
}
Kostenlos starten →